Does SECUKINUMAB Cause Cardiovascular insufficiency? 5 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Cardiovascular insufficiency have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
5
Reports of Cardiovascular insufficiency with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Cardiovascular insufficiency From SECUKINUMAB?
Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Cardiovascular insufficiency Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Cardiovascular insufficiency?
FUROSEMIDE (51)
METFORMIN (47)
AMLODIPINE (41)
SACUBITRIL\VALSARTAN (38)
SODIUM (36)
DEXAMETHASONE (34)
BISOPROLOL (32)
FLUCONAZOLE (31)
METHYLPREDNISOLONE (30)
DEXTROSE (29)
Which SECUKINUMAB Alternatives Have Lower Cardiovascular insufficiency Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG